CJC-1295 (No DAC) / Ipamorelin

About this material

This dual-peptide formulation combines CJC-1295 (No DAC), a 29-amino acid synthetic peptide analog commonly associated with the modified GHRH 1-29 sequence, with Ipamorelin, a 5-amino acid synthetic pentapeptide. Each peptide is independently manufactured using precision Solid-Phase Peptide Synthesis (SPPS) under controlled production parameters designed to ensure sequence fidelity, molecular consistency, and reproducible batch quality. Following synthesis, both components are purified using High-Performance Liquid Chromatography (HPLC) prior to formulation into a chemically defined lyophilized preparation.

Each production batch undergoes analytical characterization to verify the molecular identity of both peptide components, chromatographic purity, peptide content, formulation consistency, and overall physicochemical quality prior to release. Independent component verification supports compositional accuracy and batch-to-batch reproducibility. Every production lot is accompanied by a batch-specific Certificate of Analysis (COA) documenting analytical verification, quality control review, and complete manufacturing traceability, providing a thoroughly characterized dual-peptide material for analytical and laboratory research applications.